Literature DB >> 28320010

Sodium-Glucose Cotransporter 2 Inhibitor Improves Complications of Lipodystrophy: A Case Report.

Yohei Kawana1, Junta Imai1, Shojiro Sawada1, Tetsuya Yamada1, Hideki Katagiri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28320010     DOI： 10.7326/L16-0372

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  Treatment Options for Lipodystrophy in Children.

Authors:  Francesca Mainieri; Veronica Maria Tagi; Francesco Chiarelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

2.  Clinical Effects of Sodium-Glucose Transporter Type 2 Inhibitors in Patients With Partial Lipodystrophy.

Authors:  Rashika Bansal; Elaine Cochran; Megan Startzell; Rebecca J Brown
Journal:  Endocr Pract       Date:  2022-03-14       Impact factor: 3.701

Review 3.  Familial Partial Lipodystrophy (FPLD): Recent Insights.

Authors:  Christos Bagias; Angeliki Xiarchou; Alexandra Bargiota; Stelios Tigas
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-06       Impact factor: 3.168

4.  Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome.

Authors:  Shuichi Nagashima; Tetsuji Wakabayashi; Naoko Saito; Manabu Takahashi; Kenta Okada; Ken Ebihara; Shun Ishibashi
Journal:  J Diabetes Investig       Date:  2020-03-20       Impact factor: 4.232

5.  Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor.

Authors:  Tetsushi Hamaguchi; Yushi Hirota; Takehito Takeuchi; Yasushi Nakagawa; Atsuko Matsuoka; Masaaki Matsumoto; Hiroyuki Awano; Kazumoto Iijima; Pei Chieng Cha; Wataru Satake; Tatsushi Toda; Wataru Ogawa
Journal:  J Diabetes Investig       Date:  2018-03-25       Impact factor: 4.232

6.  Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic.

Authors:  Masanori Iwanishi; Jun Ito-Kobayashi; Miki Washiyama; Toru Kusakabe; Ken Ebihara
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

7.  Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.

Authors:  Ayako Nagayama; Kenji Ashida; Miki Watanabe; Kanoko Moritaka; Aya Sonezaki; Yoichiro Kitajima; Hirokazu Takahashi; Satoko Yoshinobu; Shimpei Iwata; Junichi Yasuda; Nao Hasuzawa; Shuichi Ozono; Seiichi Motomura; Masatoshi Nomura
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.